Patienter i behandling med Simulect bør behandles i faciliteter udstyret og bemandet med egnet laboratorie og medicinsk support ressourcer, herunder medicin til behandling af alvorlige overfølsomhedsreaktioner.
Patients receiving Simulect must be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources, including medications for the treatment of severe hypersensitivity reactions.